


Ask a doctor about a prescription for EZETIMIBE/SIMVASTATIN PHARMA COMBIX 10 mg/40 mg TABLETS
Package Leaflet: Information for the User
Ezetimibe/Simvastatin Pharma Combix 10 mg/40 mg tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of thepackage leaflet
Contents of the pack and other information
This medicine contains the active substances ezetimibe and simvastatin. It is used to reduce the levels of total cholesterol, "bad" cholesterol (LDL cholesterol) and a type of fat called triglycerides in the blood. It also increases the levels of "good" cholesterol (HDL cholesterol).
Ezetimibe/simvastatin works by reducing cholesterol in two ways. The active substance ezetimibe reduces the amount of cholesterol absorbed from the gut. The active substance simvastatin, which belongs to a group of medicines called "statins", inhibits the production of cholesterol made by the body.
Cholesterol is one of the fatty substances found in the blood. Your total cholesterol is made up mainly of LDL and HDL cholesterol.
LDL cholesterol is often called "bad" cholesterol because it can build up in the walls of your arteries, forming plaques. Over time, this can lead to a narrowing of the arteries. This narrowing can reduce or completely block the blood flow to vital organs such as the heart and brain. This blockage can cause a heart attack or stroke.
HDL cholesterol is often called "good" cholesterol because it helps prevent "bad" cholesterol from building up in the arteries and protects against heart disease.
Triglycerides are another type of fat found in your blood. High levels of triglycerides can increase your risk of heart disease.
Ezetimibe/simvastatin is used in patients who cannot control their cholesterol levels by diet alone. While taking this medicine, you should also follow a low-cholesterol diet.
Ezetimibe/simvastatin is used, along with a low-cholesterol diet, if you have:
This medicine does not help you lose weight.
Do not take Ezetimibe/Simvastatin Pharma Combix if:
Do not take more than 10/40 mg of ezetimibe/simvastatin if you are taking lomitapide (used to treat rare and serious genetic cholesterol disorders).
Consult your doctor if you are not sure if your medicine is mentioned above.
Warnings and precautions
Tell your doctor:
Your doctor will do a blood test before you start taking ezetimibe/simvastatin and may also do a blood test if you have any symptoms of liver problems while taking ezetimibe/simvastatin. This is to check how well your liver is working.
Your doctor may also want to do blood tests to check how well your liver is working after you start treatment with ezetimibe/simvastatin.
While you are taking this medicine, your doctor will check if you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high levels of sugar and fat in your blood, are overweight and have high blood pressure.
Talk to your doctor if you have severe lung disease.
The combined use of ezetimibe/simvastatin and fibrates (certain cholesterol-lowering medicines) should be avoided, as the use of ezetimibe/simvastatin with fibrates has not been studied.
Tell your doctor immediately if you experience muscle pain, tenderness or weakness. This is because, on rare occasions, muscle problems can be serious, including muscle breakdown, which can cause kidney damage; and, very rarely, deaths have occurred.
The risk of muscle breakdown is greater with higher doses of ezetimibe/simvastatin, especially the 10/80 mg dose. The risk of muscle breakdown is also greater in certain patients. Tell your doctor in the following situations:
Tell your doctor or pharmacist if you experience persistent muscle weakness. You may need to have tests and additional medicines to diagnose and treat this problem.
Children and adolescents
Other medicines and Ezetimibe/Simvastatin Pharma Combix
Tell your doctor if you are taking, have recently taken or might take any other medicines, including those obtained without a prescription. In particular, tell your doctor if you are taking or have taken any of the following:
As well as the medicines mentioned above, tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including those obtained without a prescription. In particular, tell your doctor if you are taking any of the following:
You should also tell any doctor who prescribes you a new medicine that you are taking ezetimibe/simvastatin.
Taking Ezetimibe/Simvastatin Pharma Combixwith food and drink
Grapefruit juice contains one or more components that alter the metabolism of some medicines, including ezetimibe/simvastatin. You should avoid drinking grapefruit juice, as it can increase the risk of muscle problems.
Pregnancy and breast-feeding
Do not take this medicine if you are pregnant, trying to become pregnant or think you may be pregnant. If you become pregnant while taking ezetimibe/simvastatin, stop taking it immediately and tell your doctor. Do not take ezetimibe/simvastatin if you are breast-feeding, as it is not known whether this medicine passes into breast milk.
Consult your doctor or pharmacist before using any medicine.
Driving and using machines
Ezetimibe/simvastatin is not expected to affect your ability to drive or use machines. However, it should be taken into account that some people experience dizziness after taking ezetimibe/simvastatin.
Ezetimibe/Simvastatin Pharma Combixcontains lactose
If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medicine.
Your doctor will decide on the appropriate dose of the tablet for you, depending on your current treatment and your personal risk situation.
The tablets are not scored and should not be divided.
Follow the instructions for administration of this medicine exactly as told by your doctor. If you are unsure, consult your doctor or pharmacist again.
Adults: the dose is 1 tabletof ezetimibe/simvastatin once a day by mouth.
Use in adolescents(10 to 17 years old): the dose is 1 tabletof ezetimibe/simvastatin once a day by mouth (do not exceed a maximum dose of 10 mg/40 mg once a day).
The dose of ezetimibe/simvastatin 10 mg/80 mg is only recommended for adult patients with very high cholesterol levels and a high risk of heart disease who have not reached their treatment goal with lower doses.
Take ezetimibe/simvastatin in the evening. You can take it with or without food.
If your doctor has prescribed ezetimibe/simvastatin along with another cholesterol-lowering medicine containing the active substance colestipol or any other bile acid sequestrant, you should take ezetimibe/simvastatin at least 2 hours before or 4 hours after taking the bile acid sequestrant.
If you take moreEzetimibe/Simvastatin Pharma Combixthan you should
If you forget to takeEzetimibe/Simvastatin Pharma Combix
If you stop takingEzetimibe/Simvastatin Pharma Combix
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them (see section 2. What you need to know before taking Ezetimiba/Simvastatina Pharma Combix).
The following frequent adverse effects have been reported (may affect up to 1 in 10 people):
The following infrequent adverse effects have been reported (may affect up to 1 in 100 people):
Additionally, the following adverse effects have been reported in people taking ezetimiba/simvastatina or medicines containing the active ingredients ezetimiba or simvastatina:
With some statins, the following additional adverse events have been reported:
Consult your doctor if you experience weakness in your arms or legs that worsens after periods of activity, double vision, or drooping eyelids, difficulty swallowing, or difficulty breathing
Consult your doctor immediately if you experience unexplained muscle pain, pressure sensitivity, or weakness. This is because, in rare cases, muscle problems can be serious, including muscle failure, which can cause kidney damage; and very rarely, deaths have occurred
Reporting of Adverse Effects:
If you experience any adverse effects, consult your doctor, pharmacist, or nurse, even if they are possible adverse effects that do not appear in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines:
https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine
Keep this medicine out of the sight and reach of children
Do not use this medicine after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated
This medicine does not require special storage conditions
Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and any unused medicines at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment
Composition of Ezetimiba/Simvastatina Pharma Combix
butylated hydroxyanisole, citric acid, ascorbic acid, anhydrous lactose, sodium croscarmellose,
sodium fumarate, magnesium stearate (E470b)
Appearance of the Product and Package Contents
Capsule-shaped tablets, white to off-white in color, with the engraving "14" on one side and smooth on the other
Ezetimiba/Simvastatina Pharma Combix 10 mg/40 mg is available in PVC/Aclar-Al and OPA/Al/PVC-Al blister packs, in packs of 28 tablets
Marketing Authorization Holder
Laboratorios Combix, S.L.U
C/ Badajoz 2, Edificio 2
28223 Pozuelo de Alarcón (Madrid)
Spain
Manufacturer
Zydus France
ZAC Les Hautes Patures
Parc d'activités des Peupliers
25 Rue des Peupliers
92000 Nanterre
France
or
Centre Spécialités Pharmaceutiques
ZAC des Suzots
35 rue de la Chapelle
63450 Saint Amant Tallende
France
or
Pharmex Advanced Laboratories S.L
Ctra. A-431 Km. 19
14720 Almodóvar del Río (Córdoba)
Spain
Date of the Last Revision of this Leaflet: April 2023
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of EZETIMIBE/SIMVASTATIN PHARMA COMBIX 10 mg/40 mg TABLETS in December, 2025 is around 32.72 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for EZETIMIBE/SIMVASTATIN PHARMA COMBIX 10 mg/40 mg TABLETS – subject to medical assessment and local rules.